Standout Papers

Colorectal cancer screening for average‐risk adults: 2018 guideline upda... 2015 2026 2018 2022 1.3k
  1. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society (2018)
    Andrew M. D. Wolf, Elizabeth T. H. Fontham et al. CA A Cancer Journal for Clinicians
  2. Breast Cancer Screening for Women at Average Risk (2015)
    Kevin C. Oeffinger, Elizabeth T. H. Fontham et al. JAMA
  3. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014 (2015)
    Gary H. Lyman, Kari Bohlke et al. Journal of Clinical Oncology
  4. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update (2019)
    Nigel S. Key, Alok A. Khorana et al. Journal of Clinical Oncology
  5. 2016 US lymphoid malignancy statistics by World Health Organization subtypes (2016)
    Lauren R. Teras, Carol DeSantis et al. CA A Cancer Journal for Clinicians
  6. American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer (2007)
    Gary H. Lyman, Alok A. Khorana et al. Journal of Clinical Oncology
  7. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society (2020)
    Elizabeth T. H. Fontham, Andrew M. D. Wolf et al. CA A Cancer Journal for Clinicians
  8. American Cancer Society lung cancer screening guidelines (2013)
    Richard C. Wender, Elizabeth T. H. Fontham et al. CA A Cancer Journal for Clinicians
  9. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update (2013)
    Gary H. Lyman, Alok A. Khorana et al. Journal of Clinical Oncology
  10. Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study (2015)
    Carla Casulo, Michelle Byrtek et al. Journal of Clinical Oncology
  11. Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (2019)
    Laurie H. Sehn, Alex F. Herrera et al. Journal of Clinical Oncology
  12. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update (2018)
    Randy Taplitz, Erin B. Kennedy et al. Journal of Clinical Oncology
  13. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update (2023)
    Nigel S. Key, Alok A. Khorana et al. Journal of Clinical Oncology

Immediate Impact

3 by Nobel laureates 4 from Science/Nature 78 standout
Sub-graph 1 of 19

Citing Papers

Palliative Care for Patients With Cancer: ASCO Guideline Update
2024 Standout
Screening for Breast Cancer
2024 Standout
7 intermediate papers

Works of Christopher R. Flowers being referenced

Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials
2022
Breast Cancer Screening for Women at Average Risk
2015 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Christopher R. Flowers 7056 9506 2807 2815 538 18.8k
Christoph Zielinski 1367 9866 1617 3025 497 20.3k
Richard I. Fisher 18620 16047 6067 441 333 31.0k
Katherine S. Panageas 2027 9408 2818 414 312 19.0k
Armando Santoro 8609 17399 2472 308 903 33.7k
Alok A. Khorana 1360 5595 996 12834 350 20.1k
Jamés O. Armitage 15610 12148 6072 208 476 25.1k
Christine M. Lohse 1351 6926 818 1787 613 31.5k
Ingrid Pabinger 810 2225 2323 9108 530 19.5k
J. Hermans 2331 5098 2280 170 338 20.4k
Sandra L. Wong 1836 6193 185 2148 256 12.3k

All Works

Loading papers...

Rankless by CCL
2026